Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PepHaūs vs VyrarX

By GLP-1 ScorecardUpdated

PepHaūsFactor scores not reassessed.
Site position #25

Higher score

VyrarXFactor scores not reassessed.
Site position #160

Lower score

Score comparison

PepHaūs has the higher recorded score — 82.7/100 to 68.6/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compare monthly billing with prepaid commitments, then confirm renewal pricing and supply.

Before you choose

Before comparing the headline prices, the PepHaūs review and the VyrarX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, PepHaūs vs Youth & Soul and Piper vs VyrarX compare each of them with another graded program, and the list of alternatives to PepHaūs ranks the programs closest to PepHaūs on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePepHaūs +21
82
61
Dose & formulationPepHaūs +16
80
64
Clinical oversightEven
84
84
Labs & monitoringPepHaūs +10
82
72
FulfillmentPepHaūs +15
86
71
Contract termsPepHaūs +30
85
55
PepHaūs · top barVyrarX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPepHaūsVyrarX
WeighScore82.7/10068.6/100
GradeB−C
Site position#25#160
Semaglutide$169 monthly; prepaid plans available (advertised)From $179/mo (advertised injectable program)
Tirzepatide$239 monthly; prepaid plans available (advertised)From $329/mo (advertised program)
CoverageClaims all 50 states plus DC; treatment eligibility requires confirmationCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
PepHaūs

Site position #25 · B−

Factor scores not reassessed.

Strengths

  • Publishes monthly and prepaid plan amounts
  • Names provider and pharmacy partners

What to consider

  • Price-lock wording needs reconciling with renewal terms
  • Actual supply and longer-plan shipments remain unverified
  • Independent license and certification status remain unverified
VyrarX

Site position #160 · C

Factor scores not reassessed.

Strengths

  • Publishes starting prices for both weight-loss programs
  • Advertises one-to-one provider messaging and free shipping
  • Names Rush Pharmacy in its public FAQ

What to consider

  • Starting prices do not establish the selected dose or renewal charge
  • Partial billing periods are generally not refunded
  • The homepage advertises 47 states without listing them

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard